In the latest reports, CIK cells combined with PD-1 antibody and CTLA-4 antibody have achieved significant effect in the treatment of RCC [19, 32, 33].Additionally, it reported that CIK cells could enhance the antitumor activity of CAR-T cells [34]. This evidence concerns the gene CTLA4 and renal cell carcinoma.